Varpas, UAB - financials and debts

Company age: 35 y. 7 mo.

Update

Privati narkologijos klinika Varpas - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 61,400 64,200 63,390 70,700 71,000 74,750 78,550 77,100
Profit before tax 322 475 8,697 2,524 1,121 -449 1,505 1,495
Net profit 317 454 7,694 2,145 1,065 -449 1,452 1,405
Equity 5,425 5,879 8,384 10,529 11,594 11,145 12,597 14,003
Liabilities 51 54 1,035 415 93 36 89 355
Non-current assets 0 0 0 0 0 0 0 0
Current assets 5,476 5,933 9,419 10,944 11,687 11,181 12,686 14,358
Total assets 5,476 5,933 9,419 10,944 11,687 11,181 12,686 14,358
Taxes paid
STI taxes - - - - - 11,082 11,226 10,877
Social insurance contributions - - - - - 15,487 15,851 15,459
Financial indicators
Revenue change y/y -1.6% +4.6% -1.3% +11.5% +0.4% +5.3% +5.1% -1.8%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 5.8% 7.7% 81.7% 19.6% 9.1% -4.0% 11.4% 9.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 5.8% 7.7% 91.8% 20.4% 9.2% -4.0% 11.5% 10.0%
Profit margin Net profit margin. Shows the overall profitability of the company. 0.5% 0.7% 12.1% 3.0% 1.5% -0.6% 1.8% 1.8%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 0.5% 0.7% 13.7% 3.6% 1.6% -0.6% 1.9% 1.9%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 15,350 16,050 15,848 17,675 17,750 18,688 19,638 19,275

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Privati narkologijos klinika Varpas - Social security debts

From To Debt, €
2026-05-18 2026-05-28 0.03
2026-04-20 2026-04-29 0.03
2026-03-29 2026-03-30 0.03
2026-03-17 2026-03-27 0.03
2026-02-18 2026-02-26 0.03
2026-01-21 2026-01-29 0.03
2025-12-16 2025-12-29 8.74

Privati narkologijos klinika Varpas - VMI tax arrears

From To Overdue, €
2026-06-18 2026-07-26 0.22
2026-04-08 2026-04-30 0.44
2026-04-01 2026-04-07 0.2
2026-03-08 2026-03-31 0.44
2026-02-28 2026-03-07 0.2
2026-02-07 2026-02-27 0.44
2026-01-31 2026-02-06 0.2
2026-01-05 2026-01-30 0.44
2025-12-31 2026-01-04 0.2
2025-12-05 2025-12-30 0.44
2025-06-19 2025-12-04 0.2
2025-02-06 2025-02-28 0.01

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Varpas, UAB (code 120324815) is a private limited liability company engaged in medical specialists activities. In 2025, the company generated revenue of €77.1K, slightly below €78.5K in 2024 and above €74.8K in 2023, indicating a broadly stable top-line trend over the last three years. Net profit in 2025 was €1.4K, following €1.5K in 2024 and a small loss of €449 in 2023, so profitability improved after the 2023 result and remained positive in 2025. The net profit margin was 1.8% in both 2024 and 2025. Total assets increased from €11.2K in 2023 to €12.7K in 2024 and €14.4K in 2025, while equity rose from €11.1K to €14.0K over the same period. Liabilities remained very low at €355 in 2025, supporting an equity ratio of 97.5% and a debt-to-equity ratio of 0.03. Return on equity was 10.0% and return on assets 9.8% in 2025. Revenue per employee was €19.3K, with profit per employee of €351.